17
17
41 Welcome
21 1bWelcome to CT3N
17e
CT3N's mission is to facilitate research in drug delivery and nanomedicine. We do this via our annual symposium, monthly seminar series, grants, and other activities that bring together our dozens of member faculty from Penn, CHOP, and surrounding institutions.
2026 CT3N Symposium
58Details coming soon
Hold the date: December 2, 2026
Missed the 2025 CT3N Symposium?
View the recordings
57 21 21 25 49 5 25 49 25 1f 1f 49 45 21 3b 21 25 1d
Upcoming Events
6 9 e 80 bCT3N Faculty Publication Highlights
11 22Shuvaev et al., PNAS (2025)
4d
Papp et al., Molec. Therapy (2025)
50
Faculty in the News
9 297d 5f Novel plant-based approach to a better, cheaper GLP-1 delivery system (Henry Daniell) a 7
3cTuesday, March 3, 2026
2a77 7f Penn Medicine and CHOP launch first CRISPR-based platform to pinpoint drivers of AML in patient cells (Kathrin Bernt) a 7
40Thursday, February 26, 2026
2a7f 5e Tumor-on-a-Chip Offers Insight into Cancer-Fighting Cells in Immunotherapy (Dan Huh) a 7
3dMonday, October 27, 2025
2a6d 52 Nanoparticle Blueprints Reveal Path to Smarter Medicines (Mike Mitchell) a 7
3fThursday, October 23, 2025
2a6f 56 Future mRNA vaccines may prevent food and seasonal allergies (Drew Weissman) a 7
3fFriday, September 26, 2025
3f42 More News 15
15Featured Faculty
82
Claudia Loebel, MD, PhD, Assistant Professor, Department of Bioengineering, School of Engineering and Applied Science
4d3Dr. Claudia Loebel is an Assistant Professor in the Department of Bioengineering and a core faculty member of the Penn Center for Precision Engineering for Health. She earned her medical degree from Martin Luther University Halle-Wittenberg in Germany and completed her Ph.D. at ETH Zürich, followed by postdoctoral training in the laboratory of Dr. Jason Burdick at the University of Pennsylvania. Dr. Loebel launched her independent research group at the University of Michigan in 2021 before joining the University of Pennsylvania in January 2025. Her research focuses on understanding how cells build, sense, and remodel their surrounding extracellular matrix, with a particular interest in how these dynamic matrix interactions regulate cell fate, tissue repair, and fibrosis in the lung. The Loebel lab develops engineered biomaterials, bioorthogonal labeling strategies, ex vivo tissue models, and in vivo models to study nascent extracellular matrix formation and mechanobiology in health and disease. Through this work, the lab aims to uncover how early changes in the extracellular matrix contribute to lung dysfunction and to develop new strategies to guide regeneration and prevent fibrosis.
6e 20